Cutler Group LP Glaukos Corp Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$46.84 - $58.49 $9,368 - $11,698	-200 Reduced 33.33%	400 $0
Q2 2022 Aug 04, 2022	SELL	$34.86 - $63.77 $721,602 - $1.32 Million	-20,700 Reduced 97.18%	600 $1,000
Q1 2022 Apr 14, 2022	BUY	$44.33 - $57.82 $17,732 - $23,128	400 Added 1.91%	21,300 $72,000
Q3 2021 Oct 26, 2021	BUY	$47.43 - $84.23 $948,600 - $1.68 Million	20,000 Added 2222.22%	20,900 $8,000
Q3 2018 Nov 07, 2018	BUY	$38.13 - $68.37 $15,252 - $27,348	400 Added 80.0%	900 $5,000
Q2 2018 Aug 10, 2018	SELL	$27.62 - $44.51 $16,572 - $26,706	-600 Reduced 54.55%	500 $1,000
Q4 2017 Jan 17, 2018	SELL	$24.5 - $36.01 $98,000 - $144,040	-4,000 Reduced 78.43%	1,100 $0
Q3 2017 Oct 17, 2017	BUY	$31.26 - $42.03 $159,426 - $214,353	5,100	5,100 $4,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.